News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Trump Nominates Warsh and Sets 15% Growth Target; Alphabet Issues $20 Billion Bonds; US Tech Stocks Rebound (February 10, 2026)2Bitmine buys $84 million in ETH as Tom Lee calls market pullback 'attractive' entry point: onchain data3As Palantir Projects a 61% Increase in Revenue for 2026, Is Now the Time to Invest in Palantir Shares?
Shiba Inu On-Chain Signals Could Curb Gains as Exchange Inflows Climb and EMA Resistance Persists
Coinotag·2025/09/14 12:51
ENA Gains Spotlight With $1M Hayes Bet and Mega Matrix Push
CryptoNewsNet·2025/09/14 12:18
AI, Mining News: GPU Gold Rush: Why Bitcoin Miners Are Powering AI’s Expansion
CryptoNewsNet·2025/09/14 12:18
Ethereum is worth $1 trillion, but its developers are underpaid
Cointribune·2025/09/14 12:09
Investors Brace For Fed’s Rate Cut Verdict
Cointribune·2025/09/14 12:09
Sonic (S) To Rise Higher? Key Harmonic Structure Hints at Potential Upside Move
CoinsProbe·2025/09/14 12:09
Is Cardano (ADA) Poised for a Bullish Move? This Key Fractal Formation Saying Yes!
CoinsProbe·2025/09/14 12:09
World Liberty Financial (WLFI) To Rise Further? Key Breakout Signals Potential Upside Move
CoinsProbe·2025/09/14 12:09
Will Shiba Inu Price Finally Reach $1?
Cryptoticker·2025/09/14 12:03
Flash
21:21
Edwards Lifesciences recently revealed that its management has significantly increased confidence in achieving its 2026 financial targets.According to the latest assessment, the company expects to achieve an annual sales growth rate guidance of 8% to 10%, while maintaining its earnings per share target range between $2.90 and $3.05. This positive outlook is driven by the continued market penetration of its core product lines and the commercialization progress of innovative technologies. With the structural growth in global medical demand, the company’s leading position in the heart valve therapy sector has been further strengthened, injecting strong momentum for medium- and long-term growth. Currently, the capital market’s attention to the medical technology sector continues to rise. Through precise strategic deployment and an efficient operational system, Edwards is gradually transforming its clinical advantages into sustainable financial returns. This confidence upgrade also reflects the management’s cautiously optimistic attitude towards macroeconomic fluctuations and the competitive landscape of the industry.
21:20
Special Purpose Acquisition Company Jackson Acquisition Co II recently received a non-compliance notice from the New York Stock Exchange for failing to meet the exchange’s minimum public shareholder requirement.According to the New York Stock Exchange listing rules, listed companies must maintain a certain number of public shareholders to ensure market liquidity. If this violation is not resolved within the specified remediation period, the SPAC may face the risk of delisting. Currently, Jackson Acquisition Co II states that it is actively evaluating solutions to regain compliance with regulatory standards.
21:20
According to documents submitted to the U.S. Securities and Exchange Commission (SEC) on February 5, 2026, semiconductor connectivity solutions provider Astera Labs, Inc. has reached a major transaction agreement with e-commerce giant Amazon.This agreement marks a new stage in the strategic cooperation between the two technology companies in the field of data center interconnection technology. Although the full details of the agreement disclosed in the document have not been made public, industry analysts believe it may involve the deep integration of Astera Labs' cloud-optimized interconnect technology within Amazon AWS infrastructure. This collaboration will further enhance Astera Labs' competitiveness in the AI data center solutions market, while also strengthening Amazon Cloud Services' technological advantage in the high-speed interconnect sector. Market observers point out that this deal is expected to bring significant synergies to both parties.
News